News
Amneal Pharmaceuticals LLC: Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results
Results Reflect Continued Financial Strength and Deleveraging - BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today annou ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results